Importantly, extracellularly administered TFF1 exhibit a similar function as cellular expression of TFF1, indicating that TFF1 therapy might be a promising approach for pancreatic cancer treatment in the near future. This evidence concerns the gene TFF1 and familial pancreatic carcinoma.